Cargando…
Exogenous surfactant therapy in 2013: what is next? who, when and how should we treat newborn infants in the future?
BACKGROUND: Surfactant therapy is one of the few treatments that have dramatically changed clinical practice in neonatology. In addition to respiratory distress syndrome (RDS), surfactant deficiency is observed in many other clinical situations in term and preterm infants, raising several questions...
Autores principales: | Lopez, Emmanuel, Gascoin, Géraldine, Flamant, Cyril, Merhi, Mona, Tourneux, Pierre, Baud, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851818/ https://www.ncbi.nlm.nih.gov/pubmed/24112693 http://dx.doi.org/10.1186/1471-2431-13-165 |
Ejemplares similares
-
Should we maintain baby hatches in our society?
por: Asai, Atsushi, et al.
Publicado: (2013) -
Diets for patients with chronic kidney disease, should we reconsider?
por: Mitch, William E., et al.
Publicado: (2016) -
What is presumed when we presume consent?
por: Pierscionek, Barbara K
Publicado: (2008) -
Should we restrict erythrocyte transfusion in early goal directed protocols?
por: Meybohm, Patrick, et al.
Publicado: (2015) -
Observational studies - should we simply ignore them in assessing transfusion outcomes?
por: Trentino, Kevin, et al.
Publicado: (2016)